ABCC1 Antibody

What is ABCC1 and why is it important in research?

ABCC1 is a member of the ATP-binding cassette (ABC) transporter superfamily that functions as a multispecific organic anion transporter. It transports various molecules across extra- and intra-cellular membranes, including oxidized glutathione, cysteinyl leukotrienes, and activated aflatoxin B1. ABCC1 also transports glucuronides and sulfate conjugates of steroid hormones and bile salts . Its importance in research stems from its role in multidrug resistance, particularly in cancer, where its overexpression can lead to resistance against various anticancer drugs .

What is the cellular localization of ABCC1?

ABCC1 protein is primarily localized in the plasma membrane and cell junctions, functioning as a transmembrane protein . This localization is consistent with its role as a transporter that mediates the efflux of various substrates from the cytoplasm to the extracellular space or between cells. It is characterized as a multi-pass membrane protein , indicating that it traverses the membrane multiple times with portions of the protein exposed to both the intracellular and extracellular environments.

What types of ABCC1 antibodies are available for research?

Several types of ABCC1 antibodies are available for research applications:

• Monoclonal antibodies: These include clones like MRP1-1344, which offer high specificity for ABCC1 .

• Polyclonal antibodies: These antibodies, such as the Rabbit Polyclonal Antibody (CAB3027), recognize multiple epitopes of ABCC1 and provide strong signal amplification .

Both types of antibodies have been validated for various applications including Western blot, immunohistochemistry (IHC-P), immunofluorescence (IF/ICC), and ELISA .

How should I select the appropriate ABCC1 antibody for my experiment?

When selecting an ABCC1 antibody, consider the following methodological approach:

• Application compatibility: Determine whether the antibody has been validated for your specific application (Western blot, IHC, IF, etc.). For example, CAB3027 has been validated for WB, IHC-P, IF/ICC, and ELISA with recommended dilutions for each application .

• Species reactivity: Verify that the antibody reacts with your species of interest. Some antibodies, like CAB3027, have reactivity with human, mouse, and rat samples .

• Epitope specificity: Check which region of ABCC1 the antibody recognizes. For instance, CAB3027 targets a sequence corresponding to amino acids 850-960 of human MRP1/ABCC1 .

• Positive control samples: Confirm available positive control samples for validation. For CAB3027, A-549 cells and mouse/rat brain tissues serve as positive controls .

• Clonality: Determine whether a monoclonal or polyclonal antibody better suits your needs based on specificity requirements versus signal amplification needs.

What are the recommended protocols for indirect immunofluorescence using ABCC1 antibodies?

For indirect immunofluorescence with ABCC1 antibodies, follow this methodological approach:

• Culture cells (e.g., HEK293 cells with stable expression of ABCC1) on coverslips.

• Wash cells with phosphate-buffered saline.

• Fix cells with acetone/methanol.

• Block with bovine serum albumin to prevent non-specific binding.

• Probe with primary anti-ABCC1 antibody (e.g., MRPr1) at room temperature for 1 hour.

• Incubate with appropriate secondary antibody (e.g., FITC-conjugated donkey anti-rat IgG) at room temperature for 30 minutes.

• Mount coverslips on slides before viewing with a confocal microscope .

This protocol has been successfully used to investigate the colocalization of ABCC1 with other proteins such as ATP synthase subunits .

How can ABCC1 antibodies be used to study protein-protein interactions involving ABCC1?

ABCC1 has been shown to exist as a homodimer and to form heterocomplexes with other proteins. To study these interactions:

• Co-immunoprecipitation coupled with mass spectrometry (MS/MS): Use anti-ABCC1 antibodies to pull down ABCC1 and its interacting partners, followed by MS/MS analysis to identify the components of the complex. This approach has successfully identified interactions between ABCC1 and ATP synthase subunits .

• Confocal microscopy for colocalization studies: Use dual-labeling immunofluorescence with anti-ABCC1 antibody and antibodies against potential interacting partners. For example, co-staining with anti-ABCC1 and anti-ATP synthase antibodies can reveal their spatial relationship within cells .

• Proximity ligation assays: These can detect protein-protein interactions at the single-molecule level and confirm direct physical associations between ABCC1 and other proteins.

• FRET (Fluorescence Resonance Energy Transfer): This technique can detect close proximity between fluorescently labeled proteins, providing evidence for physical interactions.

What is the role of ABCC1 in cancer progression and how can antibodies help investigate this?

ABCC1 plays significant roles in cancer progression beyond drug resistance:

• Tumor growth promotion: ABCC1 enhances cancer cell proliferation through mechanisms such as export of signaling molecules. For instance, in prostate cancer, ABCC1 promotes progression by directly exporting lysophosphatidylinositol (LPI), while in breast cancer, it exports sphingosine-1-phosphate (S1P) leading to cancer cell proliferation and migration .

• Immune modulation: ABCC1 expression correlates with immune cell infiltration, particularly macrophages in hepatocellular carcinoma (HCC) .

To investigate these roles with antibodies:

• Use immunohistochemistry with anti-ABCC1 antibodies to evaluate ABCC1 expression levels in patient tumor samples and correlate with clinical outcomes.

• Perform Western blotting to quantify ABCC1 expression in different cancer cell lines or patient-derived xenografts.

• Use immunofluorescence to study the colocalization of ABCC1 with immune cell markers in tumor tissue sections.

• Employ flow cytometry with anti-ABCC1 antibodies to sort cancer cells based on ABCC1 expression for further functional studies.

How can I detect different splice variants of ABCC1 using antibodies?

ABCC1 undergoes alternative splicing resulting in several splice variants while maintaining the original open reading frame . To detect these variants:

• Epitope-specific antibodies: Select antibodies that recognize epitopes present in specific splice variants or common regions. For example, variants like ABCC1delta-ex13, ABCC1delta-ex13&14, ABCC1delta-ex25, and ABCC1delta-ex25&26 might be distinguished by antibodies targeting their unique junctions.

• Western blot analysis: Different splice variants may show distinct molecular weights. Use high-resolution SDS-PAGE coupled with Western blotting to separate and identify them.

• Isoform-specific immunoprecipitation: Perform immunoprecipitation with antibodies that recognize common regions, followed by mass spectrometry to identify the specific isoforms present.

• Combined antibody and PCR approach: Complement antibody-based protein detection with RT-PCR using primers spanning specific exon junctions to verify the presence of different splice variants at the mRNA level.

How can ABCC1 antibodies be used in cancer prognosis research?

ABCC1 expression has significant prognostic value across multiple cancer types. Research methodologies using ABCC1 antibodies for prognostic studies include:

What methodologies can be used to study the relationship between ABCC1 expression and immune infiltration?

Recent research has revealed intriguing connections between ABCC1 and immune cell infiltration in tumors. To study this relationship:

• Multiplex immunofluorescence: Use anti-ABCC1 antibodies together with immune cell markers to simultaneously visualize ABCC1 expression and immune cell infiltration in tissue sections.

• Single-cell RNA sequencing correlation: Complement antibody-based protein detection with scRNA-seq data analysis to correlate ABCC1 expression with immune cell populations. For example, scRNA-seq analysis has revealed a positive correlation between ABCC1 expression in hepatocellular carcinoma cells and macrophage infiltration .

• Flow cytometry of tumor-infiltrating immune cells: Isolate tumor-infiltrating lymphocytes and analyze ABCC1 expression in different immune cell subsets using flow cytometry.

• Immune score correlation: Calculate immune scores using computational methods and correlate with ABCC1 expression levels determined by immunohistochemistry or Western blotting .

• In vitro co-culture systems: Use antibodies to detect changes in ABCC1 expression in cancer cells co-cultured with different immune cell populations.

What are common issues with ABCC1 antibody staining and how can they be resolved?

When working with ABCC1 antibodies, researchers may encounter several technical challenges:

How should disparate ABCC1 antibody results from different techniques be interpreted?

When facing discrepancies between results obtained with different techniques:

• Consider protein conformation: The epitope accessibility may differ between techniques. Native ABCC1 in IF/ICC may present different epitopes compared to denatured ABCC1 in Western blots.

• Evaluate detection sensitivity: Western blotting may detect total ABCC1 levels while IHC/IF provides spatial information but may be less quantitative. Use quantitative Western blotting to complement IHC data.

• Analyze subcellular localization: While ABCC1 is primarily a membrane protein , it may also be present in intracellular compartments. Different antibodies may preferentially detect ABCC1.

• Verify splice variants: Confirm whether discrepancies might be due to detection of different ABCC1 splice variants . Use RT-PCR to determine which variants are expressed in your samples.

• Validate with multiple antibodies: Use antibodies recognizing different epitopes of ABCC1 to confirm results. Compare monoclonal and polyclonal antibodies for consistency.

• Employ genetic approaches: Complement antibody-based methods with genetic approaches like siRNA knockdown or CRISPR knockout to validate specificity of antibody detection.

How are emerging technologies enhancing ABCC1 antibody-based research?

Emerging technologies are expanding the capabilities of ABCC1 antibody-based research:

• Super-resolution microscopy: Techniques like STORM and PALM allow visualization of ABCC1 distribution at nanometer resolution, providing insights into its organization in membrane microdomains.

• Antibody engineering: Development of recombinant antibody fragments with improved tissue penetration and reduced background for in vivo imaging of ABCC1.

• Proteomics integration: Combination of antibody-based pull-downs with advanced mass spectrometry to comprehensively map the ABCC1 interactome under different physiological and pathological conditions.

• Spatial transcriptomics: Correlation of ABCC1 protein expression (detected by antibodies) with gene expression profiles in specific tissue regions.

• AI-assisted image analysis: Machine learning algorithms to quantitatively analyze ABCC1 staining patterns and correlate with patient outcomes more objectively.